10 Stocks with Strong Buy Signals & High Confidence — October 2026

October 2026 Scan Reveals 10 Strong Buy Signals with High Confidence

MarketsHost.com's OpportunityRadar scan for October 01, 2026, has identified 10 compelling 'BUY' signals, with Microsoft Corporation (MSFT) leading the pack with an impressive OpportunityRadar Score of 74. MSFT, priced at $513.41, stands out with a 100% confidence rating and a 'STRONG ENTRY' signal, supported by a fundamental score of 90. Palantir Technologies Inc. (PLTR) also features prominently among the top signals, registering an OpportunityRadar Score of 69 and a 100% confidence 'STRONG ENTRY' signal at $188.27.

Out of the top 10 tickers flagged by the scanner, seven currently exhibit a 100% confidence rating for their 'BUY' signals, indicating robust alignment across underlying metrics. The average RSI for these 10 tickers is approximately 59.2, generally suggesting healthy price action without being significantly overbought or oversold. Seven of the ten tickers also show a 'BULL' MACD signal, further reinforcing positive technical momentum for a majority of the highlighted opportunities.

Top 10 Signals at a Glance

#1: MSFT — Microsoft Corporation

Microsoft Corporation (MSFT) registers the highest OpportunityRadar Score in this scan at 74, indicating a strong overall profile. The stock is currently priced at $513.41 and carries a 'BUY' signal with a 100% confidence rating, categorized as a 'STRONG ENTRY'. Its fundamental score of 90 significantly contributes to its leading position, while its technical score stands at 64. The Relative Strength Index (RSI) is at 60.6, suggesting healthy momentum without being in overbought territory. The Moving Average Convergence Divergence (MACD) is in 'BULL' territory, aligning with the positive signal. Over the past three months, MSFT has seen a substantial return of 32.75%, complemented by a 3.34% gain in the last month.

Despite the strong overall signal, the Risk/Reward ratio for MSFT is 1.5. While this indicates more potential reward than risk, it is not the highest ratio observed in the scan, suggesting that while the confidence is high, the immediate upside relative to potential downside may be moderate compared to some other opportunities with higher R/R ratios.

#2: PLTR — Palantir Technologies Inc.

Palantir Technologies Inc. (PLTR), priced at $188.27, shows a robust OpportunityRadar Score of 69, driven by a fundamental score of 80 and a technical score of 61. The scanner has issued a 'BUY' signal with a 100% confidence rating and a 'STRONG ENTRY' recommendation. Technically, PLTR's RSI is at 61.6, reflecting solid buying interest without approaching extreme levels. The MACD indicator is firmly in 'BULL' territory, reinforcing the positive momentum. The stock has demonstrated significant performance, with a 1-month return of 11.1% and an impressive 3-month return of 42.05%.

A notable factor for PLTR is its Risk/Reward ratio of 0.3. This ratio suggests that for every unit of potential reward, there are approximately 3.33 units of potential risk, which is a relatively low figure. Investors considering this 'STRONG ENTRY' signal with 100% confidence should be aware of this less favorable risk-reward balance as indicated by the scanner data.

#3: FFIV — F5, Inc.

F5, Inc. (FFIV) is highlighted with an OpportunityRadar Score of 66, comprising a technical score of 71 and a fundamental score of 58. Trading at $445.01, FFIV has a 'BUY' signal with 100% confidence and a 'STRONG ENTRY' classification. Its technical indicators show an RSI of 60.9, indicating positive momentum, and the MACD is in 'BULL' territory, further supporting the upward trend. FFIV has delivered strong short-term returns, with a 1-month gain of 13.79%, though its 3-month return of 6.2% is more modest in comparison.

The Risk/Reward ratio for FFIV stands at 0.4. Similar to other tickers in this scan, this low ratio suggests that the potential reward might be limited relative to the inherent risk. While the 100% confidence and 'STRONG ENTRY' signal are compelling, the less favorable Risk/Reward ratio is a point for consideration.

#4: IMAX — Imax Corporation

Imax Corporation (IMAX) is priced at $51.97 and holds an OpportunityRadar Score of 64, with a technical score of 72 and a fundamental score of 53. The scanner indicates a 'BUY' signal with an 83% confidence rating, classifying it as a 'STRONG ENTRY'. The RSI for IMAX is 46.3, placing it in a neutral zone. However, its MACD is currently in 'BEAR' territory, which presents a divergence from the 'BUY' signal. The stock has experienced a strong 3-month return of 39.22%, but its 1-month return is a much lower 0.56%.

The divergence between the 'BUY' signal and the 'BEAR' MACD reading for IMAX, coupled with its 83% confidence (lower than many others), warrants attention. While the Risk/Reward ratio is a favorable 2.0, the recent low 1-month return of 0.56% after a strong 3-month run suggests that recent momentum has waned, and the bearish MACD could signal further caution.

#5: AVT — Avnet, Inc.

Avnet, Inc. (AVT) shows an OpportunityRadar Score of 63, with a technical score of 68 and a fundamental score of 56. The stock, currently at $101.82, has received a 'BUY' signal with a 100% confidence rating and a 'STRONG ENTRY' recommendation. AVT's technical posture includes an RSI of 61.4, indicating healthy upward momentum. The MACD is in 'BULL' territory, reinforcing the positive signal. The company has demonstrated strong recent performance, with a 1-month return of 13.14% and a 3-month return of 23.47%.

Despite the high confidence and strong recent returns, AVT's Risk/Reward ratio is 0.3. This low ratio suggests that the potential reward is significantly less than the potential risk, which could be a concern for those prioritizing a more balanced risk-to-reward profile. The 100% confidence signal should be considered in conjunction with this specific risk metric.

#6: AME — AMETEK, Inc.

AMETEK, Inc. (AME) is trading at $248.88 and has an OpportunityRadar Score of 63, with a technical score of 66 and a fundamental score of 58. The scanner has issued a 'BUY' signal for AME, backed by a 100% confidence rating and a 'STRONG ENTRY' classification. Technical indicators show an RSI of 58.7, suggesting sustained momentum, and the MACD is in 'BULL' territory. AME's returns include a 1-month gain of 6.73% and a 3-month gain of 4.95%, indicating steady, albeit more moderate, performance compared to some other tickers on the list.

AME presents the lowest Risk/Reward ratio among the top 10 tickers at 0.2. This extremely low ratio implies a substantial amount of potential risk for each unit of potential reward. While the 100% confidence rating is positive, the unfavorable Risk/Reward ratio is a critical factor that investors should acknowledge when evaluating this 'STRONG ENTRY' opportunity.

#7: SMTI — Sanara MedTech Inc.

Sanara MedTech Inc. (SMTI), priced at $34.94, has an OpportunityRadar Score of 63, with a technical score of 69 and a fundamental score of 53. The stock carries a 'BUY' signal, but with a lower confidence rating of 67% and an 'ENTRY' signal, rather than 'STRONG ENTRY'. Its RSI stands at 61.4, indicating some positive momentum. However, the MACD is in 'BEAR' territory, creating a divergence from the 'BUY' signal. While SMTI delivered a strong 3-month return of 38.82%, its 1-month return is a minimal 0.4%.

The combination of a lower 67% confidence rating, an 'ENTRY' signal (not 'STRONG ENTRY'), and a 'BEAR' MACD reading despite the 'BUY' signal suggests caution. Furthermore, the very low 1-month return of 0.4% indicates a recent lack of upward traction, and these factors collectively present a higher degree of risk for SMTI compared to others with higher confidence and bullish MACD signals.

#8: ATRC — AtriCure, Inc.

AtriCure, Inc. (ATRC) is trading at $54.16 and holds an OpportunityRadar Score of 63, with a technical score of 67 and a fundamental score of 56. The scanner has identified a 'BUY' signal with an 83% confidence rating and a 'STRONG ENTRY' recommendation. ATRC's RSI is 49.9, indicating a neutral momentum state. However, its MACD is in 'BEAR' territory, diverging from the 'BUY' signal. The stock has shown exceptional long-term performance with a 3-month return of 67.21%, though its 1-month return is a more modest 2.99%.

Similar to IMAX, ATRC's 'BEAR' MACD signal, despite an 83% confidence 'BUY' signal, is a significant point of divergence. While the 3-month return is very strong, the recent 1-month performance is not as robust, and the bearish MACD could signal a potential shift in short-term trend. The Risk/Reward ratio is a favorable 1.8, but this must be weighed against the technical divergence.

#9: AMRX — Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. (AMRX), priced at $19.65, registers an OpportunityRadar Score of 63, with a technical score of 67 and a fundamental score of 56. The scanner has issued a 'BUY' signal for AMRX with a 100% confidence rating and a 'STRONG ENTRY' classification. Technically, AMRX's RSI is 58.4, indicating healthy momentum, and its MACD is in 'BULL' territory, aligning positively with the signal. The stock has posted solid returns, with an 8.8% gain over the last month and a 16.13% gain over the last three months.

While AMRX exhibits 100% confidence and positive technical indicators, its Risk/Reward ratio is 0.8. This ratio, being below 1.0, suggests that the potential reward is slightly less than the potential risk. This makes it a less attractive proposition from a pure risk-reward standpoint compared to opportunities with ratios greater than 1.0, despite the strong confidence in the 'BUY' signal.

#10: TMO — Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc (TMO) is currently trading at $664.55 and has an OpportunityRadar Score of 63, with a technical score of 66 and a fundamental score of 58. The scanner has identified a 'BUY' signal for TMO with a 100% confidence rating and a 'STRONG ENTRY' recommendation. Technical analysis indicates an RSI of 62.5, suggesting robust buying momentum, and the MACD is in 'BULL' territory. TMO has delivered strong returns, with a 9.2% gain in the last month and a 28.39% gain over the last three months.

Despite the high confidence and strong technical alignment, TMO's Risk/Reward ratio is 0.3. This low ratio indicates that the potential reward is considerably less than the potential risk involved. Investors prioritizing a more favorable risk-reward balance might find this aspect of TMO's profile less appealing, even with the strong 'BUY' signal and positive momentum indicators.

Key Observations Across the Scan

• Out of the 10 profiled tickers, seven – MSFT, PLTR, FFIV, AVT, AME, AMRX, and TMO – received a 100% confidence rating for their 'BUY' signals.
• A majority of the tickers, specifically seven (MSFT, PLTR, FFIV, AVT, AME, AMRX, TMO), show their MACD in 'BULL' territory, indicating positive momentum.
• The average RSI across these 10 tickers is approximately 59.2, suggesting that most are in a healthy, trending state without being significantly overbought.
• Three tickers demonstrated 1-month returns exceeding 10%: FFIV (13.79%), AVT (13.14%), and PLTR (11.1%).
• Five tickers showed substantial 3-month returns exceeding 30%: ATRC (67.21%), PLTR (42.05%), IMAX (39.22%), SMTI (38.82%), and MSFT (32.75%).
• All 10 tickers received a 'BUY' signal, with nine of them classified as 'STRONG ENTRY', and SMTI receiving an 'ENTRY' signal.

Key Risk Factors

• MACD Divergence: Imax Corporation (IMAX) and AtriCure, Inc. (ATRC) both show a MACD in 'BEAR' territory despite receiving 'BUY' signals. This divergence between the primary signal and a key momentum indicator warrants careful monitoring, especially for IMAX which also has a lower 1-month return of 0.56%.
• Unfavorable Risk/Reward Ratios: Several tickers exhibit notably low Risk/Reward ratios. AMETEK, Inc. (AME) has the lowest at 0.2, followed by Palantir Technologies Inc. (PLTR), Avnet, Inc. (AVT), and Thermo Fisher Scientific Inc (TMO) all at 0.3, and F5, Inc. (FFIV) at 0.4. These ratios suggest that the potential upside may be limited relative to the potential downside risk.
• Lower Confidence and Mixed Signals: Sanara MedTech Inc. (SMTI) stands out with a lower confidence rating of 67% and an 'ENTRY' signal instead of 'STRONG ENTRY'. Furthermore, its MACD is 'BEAR' despite the 'BUY' signal, and its 1-month return is a very low 0.4%, indicating a weaker short-term outlook compared to other high-confidence signals.

About Our Methodology

OpportunityRadar scans 6,600+ US stocks daily using 15+ technical indicators including RSI, MACD, Bollinger Bands, ADX, Aroon, support/resistance levels, and volume analysis, combined with fundamental metrics. Stocks are scored 0-100 with signals ranging from Accumulate to Strong Buy. Entry confidence is rated 50-100% based on 6 confirmation factors.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Data as of October 01, 2026.